Page 88 - IMO-2-3
P. 88

Innovative Medicines & Omics                                  Synthesis and docking of diorganotin (IV) chelates



               functional basis for recurring sulfa drug resistance mutations   37.  Lipinski CA, Lombardo F, Dominy BW,  Feeney PJ.
               in  Staphylococcus aureus dihydropteroate synthase.  Front   Experimental and computational approaches to estimate
               Microbiol. 2018;9:1369.                            solubility and permeability in drug discovery and
                                                                  development settings.  Adv Drug Deliv Rev. 1997;23(1-3):
               doi: 10.3389/fmicb.2018.01369
                                                                  3-25.
            32.  Capasso C, Supuran CT. Dihydropteroate synthase
               (sulfonamides) and dihydrofolate reductase inhibitors. In:      doi: 10.1016/S0169-409X(96)00423-1
               Bacterial Resistance to Antibiotics-From Molecules to Man.   38.  Abd-Aziz  NA, Awang N, Chan KM,  Kamaludin NF,
               New Jersey: John Wiley and Sons; 2019. p. 163-172.  Mohamad AN. Organotin (IV) dithiocarbamate compounds
                                                                  as anticancer agents: A review of syntheses and cytotoxicity
               doi: 10.1002/978111959352
                                                                  studies. Molecules. 2023;28(15):5841.
            33.  Silverstein RM, Webster FX, Kiemle DJ.  Spectrometric      doi: 10.3390/molecules28155841
                                                th
               Identification of Organic Compounds. 7   ed. Wiley:
               New York; 2005. p. 233.                         39.  Devi J, Taxak B, Kumar B, Rani S. Synthesis, characterization
                                                                  and bioactivity of diorganotin (IV) Schiff base complexes
            34.  Gielen M. An overview of forty years organotin chemistry   as potential antimalarial and antioxidant agents: Insights
               developed at the Free Universities of Brussels ULB and   through cytotoxicity and molecular docking studies. Dalton
               VUB. J Braz Chem Soc. 2003;14:870-877.
                                                                  Trans. 2025;54(18):7167-7178.
               doi: 10.1590/S0103-50532003000500021
                                                                  doi: 10.1039/D5DT00274E
            35.  Lyčka A, Holeček J, Sebald A, Tkáč I. Multinuclear NMR   40.  Caruso F, Di-Nicola C, Hanna JV,  et al. Novel bis
               study  of  some  diorgano  (chloro)  tin  (IV)  oxinates and   (β-diketonato) diorganotin (IV) derivatives containing
               thiooxinates. J Organomet Chem. 1991;409(3):331-9.
                                                                  bulky 4-acyl-5-pyrazolonato ligands: Influence of the steric
               doi: 10.1016/0022-328X(91)80019-G                  hindrance of the acyl moiety on the solid-state structures of
                                                                  tin complexes and their behaviour in solution. Inorg Chim
            36.  Koopmans T. Ordering of wave functions and Eigenenergies
               to the individual electrons of an atom.  Physica. 1933;1:   Acta. 2011;367(1):73-84.
               104-113.                                           doi: 10.1016/j.ica.2010.12.008












































            Volume 2 Issue 3 (2025)                         82                          doi: 10.36922/IMO025140019
   83   84   85   86   87   88   89   90   91   92   93